BusinessAnthera Pharmaceuticals Provides Business Update and Reports 2015 Fourth Quarter and Fiscal Year Financial ResultsBy Nasdaq OMXMar 10, 2016, 1:37 PM UTC
BusinessFibrocell Reports Fourth Quarter and Full Year 2015 Financial Results and Operational HighlightsBy Nasdaq OMXMar 10, 2016, 1:00 PM UTC
BusinessChromaDex Initiates Second Human Clinical Study on NIAGEN® -The World’s First and Only Commercially Available Form of Nicotinamide Riboside (NR)By Nasdaq OMXMar 10, 2016, 11:30 AM UTC
BusinessApricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXMar 9, 2016, 9:01 PM UTC
BusinessCatalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on Wednesday, March 16th, 2016By Nasdaq OMXMar 9, 2016, 1:03 PM UTC
BusinessTonix Pharmaceuticals Presents Pharmacokinetic Data on TNX-102 SL as a Potential Treatment for the Management of Fibromyalgia and Treatment of Post-Traumatic Stress Disorder at the ASCPT 2016 Annual MeetingBy Nasdaq OMXMar 9, 2016, 12:00 PM UTC
BusinessXenon Pharmaceuticals Reports 2015 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMar 8, 2016, 9:00 PM UTC
